Sign inJoin waitlistJoin the waitlist

AI

Alan Ikeda

. . . . . Clinical Instructor in Pediatrics, University of Hawaii John A. Burns School of Medicine. · University of Hawaii Board of Regents

Credentials: · · · ·

History

University of Hawaii Board of Regents
Present

Hematology and Medical Oncology
2005–2008
Internal Medicine
2002–2005
Univ of Hawaii John A Burns Sch of Med
1998–2002

Research

Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency
New England Journal of Medicine · 2021 · 170 citations
Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation
Review · Cancer Research · 2008 · 140 citations
Targeting CREB for cancer therapy: friend or foe
Current Cancer Drug Targets · 2010 · 137 citations

Theodore Moore
11 papers
Kathleen Sakamoto
7 papers
Tiffany Waldrip
5 papers · 4 as a resident
Satiro De Oliveira
4 papers
Donald Kohn
3 papers
GP
Geetha Puthenveetil
3 papers
Kenneth Cornetta
3 papers
Michael Hershfield
3 papers
RS
Robert Sokolic
3 papers
Tara Lin
3 papers
Ashutosh Lal
2 papers
Cecilia Fu
2 papers

Grants

NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required)
National Cancer Institute · UG1
PI · $9.6M · Southern Nevada Cancer Research Fdn
2014–2026

Clinical trials

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2028
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2030
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2031
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Site PI · Recruiting · Phase 2
Children's Oncology Group
2024–2033